Response Biomedical Corp. (RBM.TO) Announces Plan to Consolidate Outstanding Shares of Stock
Response Biomedical, based in Vancouver, British Columbia, recently announced plans to implement a consolidation of the issued and outstanding common shares. The board of directors has decided to proceed with the Consolidation, with every twenty Common Shares being consolidated into one Common Share. The Toronto Stock Exchange has conditionally approved the decision, with the anticipated consolidation to be effective on September 24, 2012; post-consolidation shares will trade on September 26, 2012. The consolidation will affect all outstanding common shares, stock options, and warrants as of the effective date. The company’s stock symbol will not change but the post-Consolidation common shares…